These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
No trial status on register 2004-001653-28 A comparison of the effects on prostaglandin synthesis and cytokine production of an olive-oil based lipid emulsion (Clinoloeic) with a soya based emulsion (Intralipid) in newborn infnats receiving pa... bad-data
Ongoing 2004-003822-80 Modulation of Sympathetic Nerve Activity By Pioglitazone In Type 2 Diabetes Mellitus not-yet-due
Ongoing 2004-004591-37 Efficacy of intrarticular steroid injection in osteoarthritis of the first carpometacarpal joint (CMCJ). not-yet-due
Ongoing 2005-000195-41 To investigate the effect of methylprednisolone on inflammatory cytokines and urinary N-acetyl-beta-D-glucosaminidase/creatinine ratio in elective aortic aneurysm repair. not-yet-due
Ongoing 2005-000803-32 Does the infiltration of Levobupivacaine into the rectus abdominus muscle ( Rectus Sheath Block) improve post-operative analgesia following open gastric bypass for morbid obesity? not-yet-due
Ongoing 2005-001203-19 Does Hyaluronidase permit volume reduction in sub-Tenon anaestehesia? not-yet-due
Ongoing 2006-000047-26 A randomized controlled trial of caudal epidural or intravenous fentanyl on the post-operative analgesia requirements after transurethral endoscopic resection of prostate, bladder neck or bladder tumo... not-yet-due
Ongoing 2006-000053-22 Eradication of Minimal Residual Disease (MRD) in patients with Chronic Lymphocytic Leukaemia (CLL) with Alemtuzumab: A Phase II Study not-yet-due
Reported results 2006-000830-11 A randomised prospective trial of tacrolimus-based steroid avoidance in renal transplantation with either alemtuzumab induction or, basiliximab induction and mycophenolate mofetil maintenance therapy 2010-11-24 due-trials
Ongoing, reported early 2006-002332-17 Prospective, randomised trial comparing the use of Tisseel versus no fibrin sealant in preventing postoperative fluid complications following liver resection not-yet-due
Ongoing, reported early 2006-005890-24 Myeloma X Relapse (Intensive) - A randomised controlled trial to determine the role of a second autologous stem cell transplant as consolidation therapy in patients with relapsed multiple myeloma foll... not-yet-due
Ongoing 2006-006362-41 An open study on the pharmacokinetics and safety of oral voriconazole in adult patients with cystic fibrosis not-yet-due
Reported results 2007-005346-20 Does nebulised tobramycin (TOBI) via e-flow delivery systems cause a raised peak serum tobramycin level in children with Cystic Fibrosis? 2009-06-26 due-trials
Ongoing 2007-006184-70 A POPULATION STUDY INTO THE PREVALENCE AND GENETIC PROFILE OF PATIENTS WITH CHRONIC PAIN WHO DO NOT RESPOND TO ORAL CODEINE not-yet-due
Ongoing 2007-007815-99 The optimal dose of subcutaneous naloxone for the treatment of intrathecal opioid- induced pruritus following elective caesarean section delivery not-yet-due
Ongoing 2007-007977-21 ASSESSMENT OF THE ROLE OF THE PROBIOTIC VSL3® IN THE TREATMENT OF POUCHITIS AFTER ILEAL POUCH-ANAL ANASTOMOSIS not-yet-due
Ongoing 2008-003012-35 CLARET: CLL Levels following Alemtuzumab in Responders to Early Therapy: A randomised, phase III trial to assess alemtuzumab consolidation therapy in patients with chronic lymphocytic leukaemia (CLL) ... not-yet-due
Ongoing, reported early 2008-004891-28 Pilot safety/tolerability study of Lenalidomide administered as monotherapy and in combination with standard chemotherapy for Acute Myeloid Leukaemia/high-risk myelodysplastic syndrome with structural... not-yet-due
Ongoing 2008-006342-25 ADMIRE: Does the ADdition of Mitoxantrone Improve REsponse to FCR chemotherapy in patients with CLL: A randomised Phase II Trial of fludarabine, cyclophosphamide and rituximab (FCR) with or without m... not-yet-due
Ongoing 2008-006349-23 CMML201: A phase 2 study of azacitidine in chronic myelomonocytic leukaemia (CMML) not-yet-due
Reported results 2008-006652-22 A multicentre, randomised, double blind, evaluative comparison trial of Rapydan® patch and Ametop® gel for topical anaesthesia during venous cannulation in adults admitted to hospital for day-case sur... 2009-09-21 due-trials
Not reported 2008-007319-33 Do genes predict response to treatment in age-related macular degeneration? 2011-07-22 due-trials
Reported results 2009-010952-81 The use of Metformin and Gonadotrophin Releasing Hormone Antagonist for the treatment of women with Polycystic Ovary Syndrome undergoing In-vitro Fertilisation-Embryo Transfer. 2014-08-28 due-trials
Ongoing 2009-010998-20 Attenuated dose Rituximab with ChemoTherapy In CLL: A randomised, phase IIB trial in previously untreated patients with Chronic Lymphocytic Leukaemia (CLL) to compare fludarabine, cyclophosphamide and... not-yet-due
Reported results 2009-017245-64 The effect of metformin co-treatment in hormone-replacement frozen embryo replacement cycles in women with polycystic ovary syndrome. 2013-05-14 due-trials
Ongoing 2010-020020-21 Comparison of the ED95 dose of 0.075% and 0.1% bupivacaine for labour analgesia in primigravida not-yet-due
Ongoing, reported early 2010-022737-28 A randomised phase II screening trial with functional imaging and patient reported toxicity sub-studies comparing LApatiNib plus capecitabine versus continued Trastuzumab plus capecitabine after local... not-yet-due
Ongoing 2011-000796-14 Chemotherapy plus Ofatumumab at Standard or Mega dose In CLL not-yet-due
Ongoing 2011-001510-33 The Efficacy of Continuous Intra-articular Infusion of Local Anaesthetic Agent following Elective Primary Hip Arthroplasty not-yet-due
Ongoing 2011-002781-21 A clinical study to evaluate the biological effects of administering rimantadine in patients with hepatitis C virus (HCV) infection alongside standard combination therapy with pegylated interferon and... not-yet-due
Ongoing 2013-004122-28 An investigator‐initiated double‐blind, parallel‐group randomised controlled trial of GOLimumab and Methotrexate versus Methotrexate in very early PsA using clinical and whole body MRI outcomes: the G... not-yet-due